Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glucosylceramide synthase-IN-2 (compound T-690) is a potent, blood-brain barrier-permeable, orally active inhibitor of glucosylceramide synthase (GCS) that acts on human GCS (IC50: 15 nM) and mouse GCS (IC50: 190 nM). Glucosylceramide synthase-IN-2 is capable of non-competitive inhibition of C8 ceramide and UDP glucose.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,620.00 | |
50 mg | 6-8 weeks | $ 2,110.00 | |
100 mg | 6-8 weeks | $ 3,150.00 |
Description | Glucosylceramide synthase-IN-2 (compound T-690) is a potent, blood-brain barrier-permeable, orally active inhibitor of glucosylceramide synthase (GCS) that acts on human GCS (IC50: 15 nM) and mouse GCS (IC50: 190 nM). Glucosylceramide synthase-IN-2 is capable of non-competitive inhibition of C8 ceramide and UDP glucose. |
Molecular Weight | 447.41 |
Formula | C22H20F3N3O4 |
CAS No. | 2597958-02-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glucosylceramide synthase-IN-2 2597958-02-4 inhibitor inhibit